Hummingbird Bioscience is a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology, and wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. We harness this integrated approach across target identification and patient selection, enabling our team to increase the efficiency of translating novel scientific insights while reducing the inherent risk in drug discovery and development. At Hummingbird Bioscience, our commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic. Sign up for our updates here: https://bit.ly/HMBDNews
Looking for a particular Hummingbird Bioscience employee's phone or email?
The Hummingbird Bioscience annual revenue was $19.6 million in 2026.
Dipti Thakkar is the COO of Hummingbird Bioscience.
62 people are employed at Hummingbird Bioscience.
The NAICS codes for Hummingbird Bioscience are [325413, 541, 32, 325, 54, 3254, 32541].
The SIC codes for Hummingbird Bioscience are [87, 873].